NEW YORK (GenomeWeb News) – Agilent Technologies and Applied Proteomics today announced a collaboration to develop multiplex protein assays and workflow solutions for multiple reaction monitoring (MRM) using mass spectrometry.

Applied Proteomics will use Agilent instruments, including the 6490 Triple Quadrupole MS/MS, 1290 Infinity LC, RapidFire 360 MS system, and Bravo liquid handling technologies to "optimize the throughput of highly multiplexed proteomic assays," the firms said.

Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.